
COVID-19 outcomes in postmenopausal and perimenopausal females: Is estrogen hormone attributing to gender differences?
Author(s) -
Ruchika Garg,
Prabhat Agrawal,
Ashish Gautam,
Nikhil Pursnani,
Meenal Agarwal,
Arti Agarwal,
Avantika Parihar,
Anjana Pandey
Publication year - 2020
Publication title -
journal of mid-life health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.423
H-Index - 11
eISSN - 0976-7819
pISSN - 0976-7800
DOI - 10.4103/jmh.jmh_287_20
Subject(s) - medicine , estrogen , mortality rate , case fatality rate , menopause , epidemiology , postmenopausal women , physiology , hormone , gynecology
Globally, case fatality rate is more in males compared to females. Some studies have suggested. It is hypothesized that estrogen hormone may decrease susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS CoV-2.).